Financial Ratios

KRSNAA DIAGNOSTICS LTD.

NSE : KRSNAABSE : 543328ISIN CODE : INE08LI01020Industry : Hospital & Healthcare ServicesHouse : Private
BSE572.7512.05 (+2.15 %)
PREV CLOSE ( ) 560.70
OPEN PRICE ( ) 563.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2650
TODAY'S LOW / HIGH ( )561.20 582.00
52 WK LOW / HIGH ( )448.7 788.6
NSE571.609.2 (+1.64 %)
PREV CLOSE( ) 562.40
OPEN PRICE ( ) 563.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 193966
TODAY'S LOW / HIGH( ) 561.50 582.50
52 WK LOW / HIGH ( )448.6 767.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)20.2322.52284.73-216.83-112.45
   CEPS(Rs)37.3635.70171.18-77.03-31.39
   DPS(Rs)2.752.500.000.000.00
   Book NAV/Share(Rs)235.63218.07-17.47-410.62-193.58
   Tax Rate(%)22.7321.0937.4129.2925.31
Margin Ratios
   Core EBITDA Margin(%)26.7729.5823.66-44.19-17.97
   EBIT Margin(%)19.3723.7681.07-51.72-27.80
   Pre Tax Margin(%)17.7119.7074.52-61.27-37.15
   PAT Margin (%)13.6815.5446.65-43.32-27.75
   Cash Profit Margin (%)25.2724.6456.09-30.78-15.49
Performance Ratios
   ROA(%)7.119.5132.24-21.88-15.35
   ROE(%)8.9221.000.000.000.00
   ROCE(%)11.9618.15129.09-225.49-43.79
   Asset Turnover(x)0.520.610.690.510.55
   Sales/Fixed Asset(x)0.831.051.160.900.92
   Working Capital/Sales(x)3.532.106.167.8713.71
Efficiency Ratios
   Fixed Capital/Sales(x)1.200.950.861.111.09
   Receivable days52.6454.0062.9483.0974.02
   Inventory Days13.476.575.656.555.37
   Payable days333.54483.54264.54525.48604.23
Valuation Parameters
   PER(x)22.7521.560.000.000.00
   PCE(x)12.3213.600.000.000.00
   Price/Book(x)1.952.230.000.000.00
   Yield(%)0.600.51
   EV/Net Sales(x)2.952.910.830.480.37
   EV/Core EBITDA(x)9.538.860.91-1.23-2.39
   EV/EBIT(x)15.2312.251.02-0.93-1.34
   EV/CE(x)1.511.510.540.230.16
   M Cap / Sales3.113.350.000.000.00
Growth Ratio
   Net Sales Growth(%)2.0214.7453.4123.51130.99
   Core EBITDA Growth(%)-3.89-58.34454.38-211.40-206.38
   EBIT Growth(%)-16.85-66.37340.44-129.84-542.71
   PAT Growth(%)-10.17-61.77265.19-92.83-1293.93
   EPS Growth(%)-10.17-92.09231.31-92.83-1293.72
Financial Stability Ratios
   Total Debt/Equity(x)0.040.061.00-1.17-1.99
   Current Ratio(x)2.382.811.341.181.09
   Quick Ratio(x)2.122.731.301.161.06
   Interest Cover(x)11.705.8512.39-5.42-2.97
   Total Debt/Mcap(x)0.020.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.